Cancer Immunoediting in the Era of Immuno-oncology.

Overview of attention for article published in Clinical Cancer Research, May 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

So far, Altmetric has seen 19 X posts from 14 X users, with an upper bound of 35,070 followers.

RT @mdvesely: Thanks @YaleCancer for highlighting our perspective on #cancer #immunoediting and #Immunotherapy published in @CCR_AACR with…

RT @mdvesely: Thanks @YaleCancer for highlighting our perspective on #cancer #immunoediting and #Immunotherapy published in @CCR_AACR with…

RT @mdvesely: Thanks @YaleCancer for highlighting our perspective on #cancer #immunoediting and #Immunotherapy published in @CCR_AACR with…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 15 additional X posts.